Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
SDI Limited is an Australian-based manufacturer and distributor of dental consumables and equipment, serving dentists, hygienists, and dental laboratories across 100+ countries. The company specializes in amalgam, composites, whitening products, and infection control solutions, with manufacturing facilities in Australia and Brazil. SDI competes in a fragmented global dental supplies market dominated by larger players like Dentsply Sirona and 3M, but maintains niche positions in specific product categories and emerging markets.
SDI generates revenue through direct sales to dental distributors and practitioners globally, with a hybrid manufacturing-distribution model. The company maintains 62.9% gross margins through proprietary formulations in niche categories (particularly amalgam alternatives and whitening systems) and cost-effective manufacturing in Australia and Brazil. Pricing power is moderate due to competition from multinational suppliers, but SDI benefits from switching costs in consumables (dentists prefer consistent materials) and regulatory barriers to entry. The business model emphasizes recurring consumable sales rather than capital equipment, providing revenue stability.
Australian dollar exchange rate movements (AUD weakness benefits exports, which represent majority of sales)
New product launches and regulatory approvals in key markets (US FDA, EU CE marking)
Dental practice utilization rates and elective procedure volumes (whitening, cosmetic dentistry)
Market share gains or losses in core geographies (Australia/NZ, Brazil, Asia-Pacific)
Raw material cost inflation (silver for amalgam, resins, chemicals)
Declining amalgam usage globally due to environmental concerns (mercury content) and shift to composite materials, threatening a legacy revenue stream
Consolidation among dental distributors reducing SDI's negotiating power and increasing pricing pressure
Regulatory complexity across 100+ markets requiring continuous investment in compliance and product registrations
Technological disruption from digital dentistry (CAD/CAM systems, 3D printing) potentially reducing demand for traditional consumables
Intense competition from multinational suppliers (Dentsply Sirona, 3M, Ivoclar Vivadent) with superior R&D budgets and distribution networks
Limited scale disadvantages in procurement, marketing, and clinical education programs compared to larger competitors
Vulnerability to private label competition in commodity product categories
Difficulty penetrating US market (largest dental market globally) due to entrenched relationships between major suppliers and large dental service organizations
Currency translation risk from AUD-denominated reporting with majority of revenue in foreign currencies (USD, BRL, EUR)
Working capital intensity in inventory (finished goods across multiple SKUs and geographies) and receivables
Limited financial flexibility for acquisitions or major capacity expansion given small market cap ($100M AUD)
moderate - Dental consumables exhibit defensive characteristics as basic restorative procedures continue during downturns, but elective/aesthetic procedures (whitening, cosmetic work) are discretionary and decline when consumer confidence weakens. The company's exposure to emerging markets (Brazil, Asia) adds cyclical sensitivity as these regions experience more volatile GDP growth. Overall, 60-70% of revenue is non-discretionary (restorative materials, infection control), providing downside protection.
Low direct sensitivity given minimal debt (0.17 D/E ratio) and limited financing costs. However, rising rates in key export markets (US, Europe) can reduce dental practice investment in equipment and inventory, indirectly affecting consumables demand. Higher rates also strengthen AUD typically, which pressures export competitiveness and reported earnings. Valuation multiples compress modestly as investors rotate from small-cap healthcare to higher-yielding alternatives.
Minimal - SDI operates with strong balance sheet (2.99x current ratio) and limited reliance on credit markets. Customer credit risk is distributed across thousands of dental practices and distributors globally. The company's access to working capital facilities is stable, and dental distributor payment terms are standard (30-60 days).
value - The stock trades at 0.9x P/S, 1.0x P/B, and 6.0x EV/EBITDA with 15% FCF yield, attracting value investors seeking undervalued small-cap healthcare exposure. The defensive characteristics of dental consumables appeal to income-focused investors despite modest dividend yield. Limited analyst coverage and small market cap mean the stock is primarily held by Australian retail investors and small-cap specialist funds rather than large institutions.
moderate-to-high - Small-cap healthcare stocks typically exhibit elevated volatility due to liquidity constraints, currency fluctuations, and binary outcomes from product launches or regulatory decisions. SDI's -8.6% 3-month and -5.6% 1-year returns reflect underperformance, likely driven by AUD strength, competitive pressures, or margin compression. Limited float and trading volume amplify price movements on company-specific news.
